ArticlePloS one2026

Repurposing Alzheimer's and ovarian cancer drugs as sonosensitizers for glioblastoma via a positive-unlabeled learning and 3D bioprinting-based new approach methodology (NAM).

Rudrajit Majumder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.